Abbott, Premier National Sponsor of Great Strides, Hits the Pavement for the CF Cause
A cold, rainy day couldn't keep Abbott away! Employees participate in the 2011 Great Strides walk in Chicago, Ill.
As one of the world’s leading pharmaceutical companies, Abbott is committed to its mission of saving lives and improving quality of life.
As the premier national sponsor of the Cystic Fibrosis Foundation’s Great Strides fundraising walks, Abbott is also dedicated to giving back to support a great cause.
“Our partnership with the CF Foundation spans 20 years and continues to remain strong,” says Jim Hynd, Divisional Vice President, Cardiovascular Care, Metabolics and GI Care at Abbott. “We’re committed to helping improve the lives of people with CF and hope to ultimately be a part of finding a cure for this disease.”
Employees Rally to Support CF Families
Through Abbott’s sponsorship of more than 600 Great Strides walks across the nation, the corporation helped raise more than $38 million last year — and employees are excited to help make the 2012 walks a huge success, too.
“Great Strides events provide an opportunity for employees to meet the inspiring families who face the challenges of CF every day,” says Hynd. “Every story we hear is extraordinary and only motivates us further to increase our efforts to band together in the search for a cure for this disease.”
“Partnering with the Cystic Fibrosis Foundation is a great way to not only give back to the community, but also to gain insights into the needs of the community we serve.”
- Jim Hynd, Divisional Vice President, Cardiovascular Care, Metabolics and GI Care at Abbott
Giving Back, Beyond Great Strides
Employees are involved in many other CF Foundation events across the nation, including the Grand Chefs Gala, Ultimate Golf Experience and Teen Advocacy Day.
Abbott also provides comprehensive nutritional, educational and financial resources to patients and their families through CFCareForward, a program that provides a range of support as patients age and their needs evolve.
“We are tremendously grateful to have Abbott as our partner in the search for a cure,” says C. Richard Mattingly, Foundation Executive Vice President and Chief Operating Officer. “Abbott has helped make possible tremendous breakthroughs in CF research and care over the past two decades, and we look forward to continuing our partnership as we accelerate our search for a cure.”
back to top